AtriCure Q2 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0
ATRC•AtriCure reports Q2 results and raises full-year outlook
Jul 23 (Reuters) - AtriCure Q2 adjusted EBITDA was USD 27.3 million versus the IBES estimate of USD 19.9 million.
- Q2 revenue: USD 153.6 million vs. IBES estimate USD 151.8 million
- Q2 gross profit: USD 118.6 million
- Q2 operating income: USD 9.7 million
- Q2 gross margin: 77.2%
- FY adjusted EPS outlook: USD 0.24–0.32 vs. IBES estimate of USD 0.06
- FY revenue outlook: USD 602–610 million vs. IBES estimate of USD 605 million
- FY adjusted EBITDA outlook: USD 85–89 million vs. IBES estimate of USD 80.5 million
